MARTHA ZEIGER, M.D.
Radiology at Falls Rd, Lutherville Timonium, MD
License number
Maryland D36424
Category
Radiology
Type
Surgery
Address
Address
2
10755 Falls Rd, Lutherville Timonium, MD 21093
PO Box 64563, Baltimore, MD 21264
PO Box 64563, Baltimore, MD 21264
Phone
(410) 955-1658
(410) 614-1197
(410) 614-1197
Organization information
See more information about MARTHA ZEIGER at bizstanding.comMartha Zeiger MD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Surgeons
Phone:
(410) 933-1233 (Phone)
Martha Allen Zeiger
Professional information
Dr. Martha Zeiger, Baltimore MD - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
600 N Wolfe St STE 1159, Baltimore 21287
(410) 614-1197 (Phone), (410) 502-1891 (Fax)
10755 Falls Rd, Lutherville 21093
(410) 955-1658 (Phone)
Baltimore Office
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone)
(410) 614-1197 (Phone), (410) 502-1891 (Fax)
10755 Falls Rd, Lutherville 21093
(410) 955-1658 (Phone)
Baltimore Office
600 N Wolfe St, Baltimore 21287
(410) 955-3071 (Phone)
Procedures:
Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Lymph Node Biopsy or Excision, Open Thymectomy, Parathyroidectomy, Thyroidectomy or Thyroid Lobectomy
Conditions:
Breast Cancer, Crohn's Disease (Regional Enteritis), Diaphragmatic/Hiatal Hernia, Hemorrhoids, Hyperparathyroidism, Parathyroid (Gland) Cancer, Parathyroid (Gland) Disease, Parathyroid (Gland) Tumor: Other than Malignant, Peripheral Vascular Disease (PAD, PVD), Secondary Malignancies, Thyroid Cancer
Certifications:
General Surgery, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 N Wolfe St STE 1159, Baltimore 21287
10755 Falls Rd, Lutherville 21093
Baltimore Office
600 N Wolfe St, Baltimore 21287
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
10755 Falls Rd, Lutherville 21093
Baltimore Office
600 N Wolfe St, Baltimore 21287
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
Education:
Medical School
University of Vermont / College of Medicine
Graduated: 1979
Maine Medical Center
Nci/Nih
University of Vermont / College of Medicine
Graduated: 1979
Maine Medical Center
Nci/Nih
Martha Allen Zeiger, Baltimore MD
Specialties:
Surgery, Endocrinology, Diabetes & Metabolism
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 JHU Surgery
10755 Falls Rd, Lutherville Timonium, MD 21093 JHU Surgery
4940 Eastern Ave, Baltimore, MD 21224
600 N Wolfe St, Baltimore, MD 21287 JHU Surgery
10755 Falls Rd, Lutherville Timonium, MD 21093 JHU Surgery
4940 Eastern Ave, Baltimore, MD 21224
Education:
University of Vermont (1979)
Alternative Splice Variant Patterns Of Human Telomerase Reverse Transcriptase (Htert) In Thyroid Tumors To Distinguish Benign From Malignant
US Patent:
2010026, Oct 14, 2010
Filed:
Dec 5, 2008
Appl. No.:
12/746418
Inventors:
Martha Allen Zeiger - Baltimore MD, US
Jeanne Kowalski - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Yongchun Wang - Baltimore MD, US
Jeanne Kowalski - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Yongchun Wang - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 51/00, C12Q 1/68, A61P 25/00
US Classification:
424 161, 435 6
Abstract:
This invention relates, e.g., to a method for determining if a thyroid tumor in a subject is malignant, comprising determining in a sample from the subject the amount of TERT (telomerase reverse transcriptase) mRNA which lacks the β sequence and the amount of TERT mRNA in the sample which comprises the β sequence, wherein a preponderance (e.g., at least about 55%) of TERT mRNA in the sample which comprises the β sequence indicates that the tumor is malignant, and wherein a preponderance of TERT mRNA which lacks the β sequence indicates that the tumor is not malignant.
Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions
US Patent:
2008014, Jun 19, 2008
Filed:
Apr 11, 2005
Appl. No.:
11/547995
Inventors:
Steven K. Libutti - North Potomac MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
International Classification:
C12Q 1/68, C12Q 1/02, C40B 30/06
US Classification:
435 6, 435 29, 506 9
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
Compositions And Methods For Characterizing And Treating Neoplasia
US Patent:
2012011, May 10, 2012
Filed:
Mar 10, 2010
Appl. No.:
13/255780
Inventors:
Radharani Marik - Baltimore MD, US
Christopher B. Umbricht - Baltimore MD, US
Martha A. Zeiger - Baltimore MD, US
Christopher B. Umbricht - Baltimore MD, US
Martha A. Zeiger - Baltimore MD, US
Assignee:
The John Hopkins University - Baltimore MD
International Classification:
C12Q 1/68, C07H 21/04, A61K 31/167, A61P 35/00, A61K 31/4353, A61K 31/165, A61K 31/166, A61K 31/706, A61K 31/593, A61K 31/19
US Classification:
514 43, 435 612, 514167, 536 2433, 514575, 514557, 514300, 514620
Abstract:
The invention features compositions and methods for characterizing the methylation status of the Vitamin D Receptor (VDR) in neoplasia (e.g., breast carcinoma), selecting an appropriate therapy, and treating the neoplasia (e.g., breast carcinoma).
Method For Diagnosing The Stage Of A Thyroid Tumor
US Patent:
2011017, Jul 21, 2011
Filed:
Feb 10, 2011
Appl. No.:
13/024845
Inventors:
Steven K. Libutti - North Potomac MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
Chiara Mazzanti - Pisa, IT
Martha Zeiger - Baltimore MD, US
Christopher Umbricht - Baltimore MD, US
International Classification:
C40B 30/06, C12Q 1/68
US Classification:
506 10, 435 614, 435 611
Abstract:
The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.